Mobia Medical, Inc. (NASDAQ:MOBI – Get Free Report) saw a significant growth in short interest during the month of June. As of June 15th, there was short interest totaling 827,893 shares, a growth of 140.3% from the May 31st total of 344,480 shares. Approximately 2.5% of the company’s stock are sold short. Based on an average daily volume of 247,511 shares, the short-interest ratio is currently 3.3 days.
Analyst Ratings Changes
A number of research analysts recently weighed in on MOBI shares. JPMorgan Chase & Co. initiated coverage on Mobia Medical in a report on Tuesday, June 2nd. They set an “overweight” rating and a $15.00 price objective on the stock. Wall Street Zen raised Mobia Medical from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th. Zacks Research upgraded shares of Mobia Medical to a “hold” rating in a research report on Wednesday, June 3rd. BTIG Research initiated coverage on Mobia Medical in a research report on Tuesday, June 2nd. They set a “buy” rating and a $19.00 price target for the company. Finally, Wolfe Research assumed coverage on Mobia Medical in a research report on Tuesday, June 2nd. They issued an “outperform” rating on the stock. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.25.
View Our Latest Stock Analysis on MOBI
Mobia Medical Stock Performance
Mobia Medical (NASDAQ:MOBI – Get Free Report) last issued its quarterly earnings results on Thursday, June 4th. The company reported $999.00 EPS for the quarter. The company had revenue of $12.07 million for the quarter.
Insider Activity at Mobia Medical
In related news, major shareholder Osage University Gp Iii, Llc acquired 533,333 shares of Mobia Medical stock in a transaction dated Monday, May 11th. The stock was acquired at an average price of $15.00 per share, for a total transaction of $7,999,995.00. Following the transaction, the insider owned 2,006,716 shares of the company’s stock, valued at $30,100,740. This represents a 36.20% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Nelson Bunker Curnes bought 5,000 shares of the business’s stock in a transaction dated Tuesday, June 9th. The shares were purchased at an average price of $12.79 per share, for a total transaction of $63,950.00. Following the transaction, the chief financial officer directly owned 366,997 shares of the company’s stock, valued at approximately $4,693,891.63. This represents a 1.38% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 1,273,332 shares of company stock valued at $19,088,930 in the last quarter.
Featured Articles
- Five stocks we like better than Mobia Medical
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Mobia Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mobia Medical and related companies with MarketBeat.com's FREE daily email newsletter.
